Taiwan Bio Therapeutics Co., Ltd (6892.TWO)

TWD 38.9

(-0.13%)

Annual Cash Flows

(In TWD)
Breakdown 2023 2022 2021 2020 2019
Operating Cash Flow -166.54 Million -139.98 Million -59.15 Million -30.36 Million -
Net Income -217.51 Million -188.01 Million -90.2 Million -35.03 Million -
Depreciation & Amortization 66.23 Million 53.13 Million 28.9 Million 2.65 Million -
Deferred income taxes - - - - -
Stock-based compensation 8.99 Million 12.41 Million 7.32 Million - -
Change in working capital -24.34 Million -14.86 Million -5.79 Million 2.29 Million -
Other non-cash items 2.86 Million 1.49 Million 3.09 Million -177 Thousand -
Investing Cash Flow -119.22 Million -103.17 Million -178.97 Million -24.5 Million -
Investments in PPE -119.23 Million -83.17 Million -174.69 Million -31.11 Million -
Acquisitions - - - - -
Investment purchases - -20 Million - - -
Sales/Maturities of investments - - - 8.4 Million 450 Thousand
Other Investing Activities 2000.00 5000.00 -4.28 Million -1.79 Million -
Financing Cash Flow 290.43 Million 429.34 Million 261.32 Million 68.82 Million -
Debt repayment - - - - -
Dividends payments - - - - -
Common Stock Repurchased - - - - -
Common Stock Issuance 308.36 Million 446.48 Million 270 Million 70 Million -
Other Financing Activities -17.93 Million 1.04 Million 2.18 Million - -
Accounts receivables -19.53 Million - - - -
Accounts payables - - - - -
Inventory -10.17 Million -25.24 Million -5.54 Million - -
Other working capital 5.36 Million - - - -
Cash at beginning of period 245.89 Million 59.7 Million 36.5 Million 22.54 Million -
Cash at end of period 248.13 Million 245.89 Million 59.7 Million 36.5 Million -
Capital Expenditure -119.23 Million -83.17 Million -174.69 Million -31.11 Million -
Effect of forex changes on cash -2.41 Million - - - -
Net cash flow / Change in cash 2.24 Million 186.19 Million 23.19 Million 13.96 Million -
Free Cash Flow -285.78 Million -223.16 Million -233.84 Million -61.47 Million -

Cash Flow Charts